布地奈德聯(lián)合多索茶堿治療支氣管哮喘的臨床效果觀察
打開文本圖片集
【摘 要】目的：探討布地奈德聯(lián)合多索茶堿治療支氣管哮喘的臨床效果。方法：選取2018年1月到2020年12月我中心收治的200例支氣管哮喘患者，隨機分成兩組。對照組霧化吸入劑量為400μg的布地奈德治療，每天兩次；觀察組聯(lián)合服用劑量為0.2g的多索茶堿治療，每天兩次。結果：觀察組的治療有效率明顯高于對照組（P
【關鍵詞】布地奈德；多索茶堿；支氣管哮喘
Clinical observation of budesonide combined with doxofylline in the treatment of bronchial asthma
CHEN Rui
Guiyang public health treatment center， Guiyang， Guizhou 550002， China
【Abstract】Objective： To investigate the clinical effect of budesonide combined with doxofylline in the treatment of bronchial asthma. Methods： 200 patients with bronchial asthma treated in our center from January 2018 to December 2020 were randomly divided into two groups. The dose of atomization inhalation in the control group was 400ug of budesonide， twice a day； The observation group was treated with doxofylline at a dose of 0.2g twice a day. Results： The effective rate of the observation group was significantly higher than that of the control group （P
【Key？Words】Budesonide； Doxofylline； bronchial asthma
支氣管哮喘主要表現(xiàn)為咳嗽、喘息、呼吸困難和胸悶等，在急性發(fā)作時，容易引起呼吸衰竭或（和）肺功能障礙[1]。（剩余3537字）